Mu‐Hung Tsai

Biomarker analyses in the phase III ASCENT study of sacituzumab govitecan versus chemotherapy in patients with metastatic triple-negative breast cancer

Aditya Bardia, Sara M. Tolaney, Kevin Punie et al. · Annals of Oncology · 2021 · 274 citations · Full text

Breast Oncology, Medicine, Pathology +5

Final results of a randomized phase III trial of induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in patients with stage IVA and IVB nasopharyngeal carcinoma-Taiwan Cooperative Oncology Group (TCOG) 1303 Study

Ruey‐Long Hong, Chin‐Fu Hsiao, Lai‐Lei Ting et al. · Annals of Oncology · 2018 · 131 citations · Full text

Development and Validation of a Nomogram for Assessing Survival in Patients With Metastatic Lung Cancer Referred for Radiotherapy for Bone Metastases

Wing-Keen Yap, Ming‐Chieh Shih, Chin Kuo et al. · JAMA Network Open · 2018 · 52 citations · Full text

Adjuvant radiotherapy after curative surgery for oral cavity squamous cell carcinoma and treatment effect of timing and duration on outcome—A Taiwan Cancer Registry national database analysis

Yung‐Jen Cheng, Mu‐Hung Tsai, Chun‐Ju Chiang et al. · Cancer Medicine · 2018 · 39 citations · Full text

Surgical Oncology, Epidemiology Of Cancer, Treatment Effect +17

Three control flow obfuscation methods for Java software

Ting‐Wei Hou, Y-H. Chen, Mu‐Hung Tsai · IEE Proceedings - Software · 2006 · 38 citations

Engineering, Information Security, Formal Verification +16